HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users

Completed · Phase 2

Conditions studied: HIV, Drug Use Disorders

In brief

HIV infected drug users have greater difficulty adhering to highly active antiretroviral therapy compared to non-drug users. As sustained adherence to highly active antiretroviral therapy is critical to reducing HIV related morbidity, mortality, and reducing the spread of HIV, innovative and potentially sustainable treatment strategies that can optimize the durability of adherence enhancing interventions among drug users is urgently needed. The goal of this study is to further develop and pilot test a smartphone based intervention called HEART (Helping Enhance Adherence to Retroviral therapy using Technology) to HAART, to enhance adherence to HAART among HIV infected drug users.

Key facts

Study ID

NCT01413529

Run by

University of Maryland, Baltimore

People needed

35

Starts

2011-09-01

Expected to finish

2015-04-01

Last updated by the study team

2022-01-20

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of HIV
• English speaking
• History of drug use in the last 6 months
• Able to carry a cell phone
• Able to read English
• Starting or switching to a new anti-retroviral medications
• Receiving care in a clinic participating in the study

You may not qualify if…

• Clinical problems that would not allow someone to use a cell phone or fulfill study procedures.

Where it is running

• Jacques Initiative — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.